JPS4843506B1 - - Google Patents

Info

Publication number
JPS4843506B1
JPS4843506B1 JP46012268A JP1226871A JPS4843506B1 JP S4843506 B1 JPS4843506 B1 JP S4843506B1 JP 46012268 A JP46012268 A JP 46012268A JP 1226871 A JP1226871 A JP 1226871A JP S4843506 B1 JPS4843506 B1 JP S4843506B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP46012268A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691918142 external-priority patent/DE1918142A1/de
Priority claimed from DE19691920365 external-priority patent/DE1920365A1/de
Application filed filed Critical
Publication of JPS4843506B1 publication Critical patent/JPS4843506B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
JP46012268A 1965-03-25 1971-03-09 Pending JPS4843506B1 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB12626/65A GB1144905A (en) 1965-03-25 1965-03-25 Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB5241465 1965-12-09
GB5374465 1965-12-17
GB37765/68A GB1144906A (en) 1965-03-25 1968-08-07 Bis-phenoxy derivatives
DE19691918142 DE1918142A1 (de) 1969-04-10 1969-04-10 Verfahren zur Herstellung von Bischromonverbindungen
DE19691920365 DE1920365A1 (de) 1969-04-22 1969-04-22 Verfahren zur Herstellung von Bis-Chromonen

Publications (1)

Publication Number Publication Date
JPS4843506B1 true JPS4843506B1 (ja) 1973-12-19

Family

ID=27544127

Family Applications (5)

Application Number Title Priority Date Filing Date
JP11131870A Pending JPS5341662B1 (ja) 1965-03-25 1970-12-15
JP11255570A Pending JPS5341663B1 (ja) 1965-03-25 1970-12-17
JP711258A Pending JPS5343492B1 (ja) 1965-03-25 1971-01-20
JP46012268A Pending JPS4843506B1 (ja) 1965-03-25 1971-03-09
JP1282771A Pending JPS5343493B1 (ja) 1965-03-25 1971-03-11

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP11131870A Pending JPS5341662B1 (ja) 1965-03-25 1970-12-15
JP11255570A Pending JPS5341663B1 (ja) 1965-03-25 1970-12-17
JP711258A Pending JPS5343492B1 (ja) 1965-03-25 1971-01-20

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP1282771A Pending JPS5343493B1 (ja) 1965-03-25 1971-03-11

Country Status (16)

Country Link
US (2) US3419578A (ja)
JP (5) JPS5341662B1 (ja)
BE (1) BE678175A (ja)
CH (1) CH486445A (ja)
DE (1) DE1543579C3 (ja)
DK (4) DK134646B (ja)
FR (1) FR5452M (ja)
GB (2) GB1144905A (ja)
IL (1) IL25317A (ja)
IT (1) IT1047628B (ja)
MY (1) MY7000043A (ja)
NL (1) NL147732B (ja)
NO (3) NO124875B (ja)
OA (1) OA03872A (ja)
SE (3) SE355184B (ja)
YU (1) YU32999B (ja)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862175A (en) * 1965-03-25 1975-01-21 Fison House Bis-chromone compounds
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
US3860618A (en) * 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them
GB1340512A (en) * 1970-01-21 1973-12-12 Fisons Ltd Production of esters of chromone-2-carboxylic acids
GB1326745A (en) * 1970-04-25 1973-08-15 Fisons Ltd Chromone-2-carboxylic acid derivatives
US3979407A (en) * 1970-07-31 1976-09-07 Allen & Hanburys Limited Chromone derivatives
US4029802A (en) * 1970-08-27 1977-06-14 Fisons Limited The treatment of asthma, hay fever or urticaria
US3968235A (en) 1970-12-14 1976-07-06 Sandoz Ltd. Composition and method for combating insects with alkylenedioxyphenyl derivatives
US3933804A (en) 1970-12-14 1976-01-20 Sandoz Ltd., (Sandoz Ag) Insecticidal 1,3-benzodioxol derivatives
US4105781A (en) * 1970-12-30 1978-08-08 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
US3965122A (en) * 1970-12-30 1976-06-22 Fujisawa Pharmaceutical Co., Ltd. Chromone compounds and preparation thereof
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
US3975536A (en) 1971-05-12 1976-08-17 Fisons Limited Composition
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4006245A (en) * 1971-07-29 1977-02-01 Fisons Limited Chemical compounds
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
SU469247A3 (ru) * 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
GB1428186A (en) * 1972-06-21 1976-03-17 Fujisawa Pharmaceutical Co Chromone derivatives
FR2196795A1 (en) * 1972-08-25 1974-03-22 Aries Robert Amine salts of bis(carboxychromones) - useful for treatment of dyspnoea and bronchoconstriction
GB1399647A (en) * 1972-12-15 1975-07-02 Fisons Ltd Phenoxyalkoxy-chromone derivatives processes for their preparation and compositions containing them
FR2210398A1 (en) * 1972-12-20 1974-07-12 Aries Robert Bis-(carboxy-chromone) amino ethoxy-ethyl carboxylate salts - useful as a sedative and prophylactic
US3948954A (en) * 1973-01-19 1976-04-06 Fisons Limited Bis-chromone-tetrazole/hydroxamic/carboxylic acids
FR2217004A1 (en) * 1973-02-15 1974-09-06 Aries Robert Sedatives and bronchodilatories - i.e. salts of 1,3-bis(2-carboxychromon-5-yloxy)propanes with 3-hydroxy-2-hydroxymethyl pyridines
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
US4046910A (en) * 1974-01-28 1977-09-06 The Upjohn Company Dosage schedule
IL48360A (en) * 1974-11-09 1978-12-17 Fisons Ltd Pharmaceutical compositions for the treatment of aphthous stomatitis comprising 1,3-bis-(2-carboxychromon-5-yloxy)-2-carboxychromon-5-yloxy)-2-hydroxypropane
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4067992A (en) * 1975-09-10 1978-01-10 Fisons Limited Method of treating a psychiatric condition
US4145438A (en) * 1975-09-10 1979-03-20 Fisons Limited Method for treatment of eczema or psoriasis
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin
US4097596A (en) * 1976-11-02 1978-06-27 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
GB1557082A (en) * 1977-01-25 1979-12-05 Fisons Ltd Pharmaceutical mixture containing an antiinflammatory
US4192860A (en) * 1977-05-06 1980-03-11 Fisons Limited Methods for treating disease conditions
NZ187192A (en) * 1977-05-06 1982-02-23 Fisons Ltd Prophylactic or curative treatment of allergic conditions in domestic animals using compounds with sodium cromoglycate-like activity
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
ZA805478B (en) * 1979-09-05 1981-09-30 Glaxo Group Ltd Phenol derivatives
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
DE3265715D1 (en) * 1981-03-24 1985-10-03 Fisons Plc Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
JPS5828509U (ja) * 1981-08-20 1983-02-24 関東電気工事株式会社 分岐箇所用低圧ロ−ラ
US4584315A (en) * 1981-11-16 1986-04-22 The Upjohn Company Method of treating ischemic states
US4447449A (en) * 1981-11-16 1984-05-08 The Upjohn Company Methods of treating ischemic states
US5135940A (en) * 1982-09-23 1992-08-04 Merck Frosst Canada, Inc. Leukotriene antagonists
US4782176A (en) * 1983-01-24 1988-11-01 Hoffmann-La Roche Inc. Phenoxycarboxylic acids
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
ATE90076T1 (de) 1986-03-27 1993-06-15 Merck Frosst Canada Inc Tetrahydrocarbazole ester.
US4758678A (en) * 1986-07-18 1988-07-19 Pennwalt Corporation Preparation of 7-(2,3-epoxypropoxy)flavone
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
CA2053216C (en) 1990-10-12 2003-04-08 Michel L. Belley Saturated hydroxyalkylquinoline acids as leukotriene antagonists
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
GB9317752D0 (en) * 1993-08-26 1993-10-13 Fisons Plc New pharmaceutical use
US5508451A (en) * 1994-07-07 1996-04-16 Hoechst Celanese Corporation Process for the preparation of dialkali metal cromoglycates
MX9704550A (es) 1994-12-22 1997-10-31 Astra Ab Formulaciones de medicamentos en aerosol.
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
JPH10511090A (ja) * 1994-12-22 1998-10-27 アストラ・アクチエボラーグ 副甲状腺ホルモン,pth含有吸入用治療製剤
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
CA2174583A1 (en) * 1995-05-05 1996-11-06 Alexander Chucholowski Sulfuric acid esters of sugar alcohols
US6150400A (en) * 1997-06-30 2000-11-21 Presutti Laboratories Method for treating vulvar vestibulitis
US6596284B1 (en) 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US9095621B2 (en) 2008-04-25 2015-08-04 Nektar Therapeutics Oligome-bis-chromonyl compound conjugates
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
ES2733214T3 (es) 2009-01-29 2019-11-28 Massachusetts Gen Hospital Derivados de cromolina y métodos relacionados de formación de imágenes y tratamiento
TR201000733A2 (tr) 2010-02-02 2011-08-22 Bi̇lgi̇ç Mahmut Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
EP2764863B1 (en) * 2011-10-03 2020-03-11 National Center for Geriatrics and Gerontology Tau aggregation inhibitor
CN109846862A (zh) 2012-10-25 2019-06-07 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
EP2962687B1 (en) 2013-04-02 2019-06-05 The Doshisha Tau aggregation inhibitor
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
JP2016534063A (ja) 2013-10-22 2016-11-04 ザ ジェネラル ホスピタル コーポレイション クロモリン誘導体ならびに関連するイメージングおよび治療方法
SI3104853T1 (sl) 2014-02-10 2020-03-31 Respivant Sciences Gmbh Zdravljenje s stabilizatorji mastocitov za sistemske motnje
CA2938996A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the treatment of lung diseases with mast cell stabilizers
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
KR20190044647A (ko) 2016-08-31 2019-04-30 더 제너럴 하스피탈 코포레이션 신경변성 질환과 관련된 신경-염증에서 대식세포/미세아교세포
AU2017321495A1 (en) 2016-08-31 2019-03-21 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
WO2018067341A1 (en) 2016-10-07 2018-04-12 Patara Pharma, LLC Cromolyn compositions for treatment of pulmonary fibrosis
KR20210070232A (ko) 2017-07-20 2021-06-14 아즈테라피즈 인코포레이티드 크로몰린 나트륨 및 이부프로펜의 분말화된 제형
CA3105392A1 (en) 2018-07-02 2020-01-09 The General Hospital Corporation Powdered formulations of cromolyn sodium and .alpha.-lactose
US20220387408A1 (en) 2019-11-12 2022-12-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2769015A (en) * 1954-10-06 1956-10-30 Lab Laroche Navarron Process of preparing 3-methyl-chromone
US3162673A (en) * 1960-12-28 1964-12-22 Union Carbide Corp Bis (aminoaliphatic) carbonates and process for preparation
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
SE372941B (ja) 1975-01-20
NL147732B (nl) 1975-11-17
SE371185B (ja) 1974-11-11
OA03872A (fr) 1971-12-24
IT1047628B (it) 1980-10-20
US3671625A (en) 1972-06-20
DE1543579B2 (de) 1980-01-03
JPS5343492B1 (ja) 1978-11-20
FR5452M (ja) 1967-10-16
MY7000043A (en) 1970-12-31
BE678175A (ja) 1966-09-21
JPS5341663B1 (ja) 1978-11-06
IL25317A (en) 1970-08-19
SE355184B (ja) 1973-04-09
DK128318B (da) 1974-04-08
GB1144906A (en) 1969-03-12
DK128245B (da) 1974-03-25
NO124875B (ja) 1972-06-19
DE1543579A1 (de) 1969-11-06
YU177066A (en) 1975-08-31
DE1543579C3 (de) 1980-08-28
DK134646C (ja) 1977-05-16
YU32999B (en) 1976-03-31
CH486445A (fr) 1970-02-28
NO137497C (no) 1978-03-08
NL6603997A (ja) 1966-09-26
NO124832B (ja) 1972-06-12
DK128353B (da) 1974-04-16
JPS5343493B1 (ja) 1978-11-20
GB1144905A (en) 1969-03-12
US3419578A (en) 1968-12-31
NO137497B (no) 1977-11-28
DK134646B (da) 1976-12-13
JPS5341662B1 (ja) 1978-11-06

Similar Documents

Publication Publication Date Title
JPS4843506B1 (ja)
JPS4323518Y1 (ja)
JPS4326873B1 (ja)
JPS4219039Y1 (ja)
JPS4913989B1 (ja)
JPS4116235Y1 (ja)
JPS431175Y1 (ja)
JPS4322375Y1 (ja)
JPS435175Y1 (ja)
NO132931C (ja)
BE675148A (ja)
BE675002A (ja)
NL6517076A (ja)
NL6600299A (ja)
NL6609079A (ja)
NL6614604A (ja)
SE320889B (ja)
BE687786A (ja)
BE675553A (ja)
BE675433A (ja)
BE675428A (ja)
BE675223A (ja)
BE675194A (ja)
BE675161A (ja)
BE674737A (ja)